Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04697472 · ClinicalTrials.gov registry record · NA

The Up-LIFT Study of Non-Invasive ARC Therapy for Spinal Cord Injury

A NA study, sponsored by ONWARD Medical.

Completed
Registry status
NA
Development phase
65
Enrollment target

NCT04697472: Completed NA study, sponsored by ONWARD Medical.

NCT04697472 is a NA study that has completed, run by ONWARD Medical. The registered enrollment target is 65 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04697472, a NA study, has completed, sponsored by ONWARD Medical.

COMPLETED
Registry status
NA
Development phase
65 participants
Enrollment target

Study Summary

The Up-LIFT Study is a prospective, single-arm study designed to evaluate the safety and effectiveness of non-invasive electrical spinal cord stimulation (ARC Therapy) administered by the LIFT System to treat upper extremity functional deficits in people with chronic tetraplegia.

Primary Outcome

Safety demonstrated through observational data regarding the incidence of serious adverse events (SAEs) related to the use of the study device and treatment procedures will be reported.

Interventions

  • DEVICE LIFT System

Trial Details

FieldValue
Enrollment Target 65 participants
Start Date 2021-01-08
Est. Completion 2022-09-13
Phase NA
ONWARD Medical

3 total trials

What the finished NCT04697472 record still lists

NCT04697472 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 65 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 1 intervention - of which LIFT System is the first listed.

NCT04697472 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04697472 about?

NCT04697472 is a clinical study titled "The Up-LIFT Study of Non-Invasive ARC Therapy for Spinal Cord Injury". The Up-LIFT Study is a prospective, single-arm study designed to evaluate the safety and effectiveness of non-invasive electrical spinal cord stimulation (ARC Therapy) administered by the LIFT System to treat upper extremity functional deficits in people with chronic tetraplegia.

What is the current status of trial NCT04697472?

This trial is currently completed. It is a NA study. The enrollment target is 65 participants. The study started on 2021-01-08. Estimated completion is 2022-09-13.

What interventions are being tested in trial NCT04697472?

The interventions under investigation include: LIFT System (DEVICE).

Who is sponsoring clinical trial NCT04697472?

This trial is sponsored by ONWARD Medical, which has 3 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04697472's enrollment target sits among peer trials

65 1144th of 2000 higher than 854 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03366116 · 65 participants · Phase 1

    5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors

  • NCT03603730 · 65 participants · NA

    Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis

  • NCT03796559 · 65 participants · NA

    Magseed Enabled Long-Term Localization of Axillary Lymph Nodes

  • NCT03993106 · 65 participants · Phase 2

    A Study of sEphB4-HSA in Kaposi Sarcoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04697472, the US trial registry maintained by the National Library of Medicine. NCT04697472 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.